Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Lozanski

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 11, 2015
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)Yvonne A Efebera, Susan Geyer, Leslie Andritsos, et al.
Leukemia|May 22, 2021
Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeqCaner Saygin, Eileen Hu, Pu Zhang, et al.
Blood|March 23, 2021
Phase 2 study of ibrutinib in classic and variant hairy cell leukemiaKerry A Rogers, Leslie A Andritsos, Lai Wei, et al.
Leukemia|September 4, 2021
Correction: Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeqCaner Saygin, Eileen Hu, Pu Zhang, et al.
Blood Advances|January 4, 2018
Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinibCecelia R Miller, Amy S Ruppert, Nyla A Heerema, et al.
Cancer Cell|May 26, 2012
Tetraspanin CD37 directly mediates transduction of survival and apoptotic signalsRosa Lapalombella, Yuh-Ying Yeh, Liwen Wang, et al.
The New England Journal of Medicine|May 30, 2014
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinibJennifer A Woyach, Richard R Furman, Ta-Ming Liu, et al.
Haematologica|August 8, 2024
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemiaJanani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, et al.
Nature Medicine|October 10, 2023
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Nature Medicine|September 13, 2022
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 11, 2015
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)Yvonne A Efebera, Susan Geyer, Leslie Andritsos, et al.
Leukemia|May 22, 2021
Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeqCaner Saygin, Eileen Hu, Pu Zhang, et al.
Blood|March 23, 2021
Phase 2 study of ibrutinib in classic and variant hairy cell leukemiaKerry A Rogers, Leslie A Andritsos, Lai Wei, et al.
Leukemia|September 4, 2021
Correction: Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeqCaner Saygin, Eileen Hu, Pu Zhang, et al.
Blood Advances|January 4, 2018
Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinibCecelia R Miller, Amy S Ruppert, Nyla A Heerema, et al.
Cancer Cell|May 26, 2012
Tetraspanin CD37 directly mediates transduction of survival and apoptotic signalsRosa Lapalombella, Yuh-Ying Yeh, Liwen Wang, et al.
The New England Journal of Medicine|May 30, 2014
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinibJennifer A Woyach, Richard R Furman, Ta-Ming Liu, et al.
Haematologica|August 8, 2024
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemiaJanani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, et al.
Nature Medicine|October 10, 2023
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Nature Medicine|September 13, 2022
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Pageof 14